The Asia-Pacific region was the largest regional market for astaxanthin in 2016. The growing awareness of the importance of antioxidants such as astaxanthin in the human diet, the high consumption of astaxanthin from the aquafeed industry, and increasing demand for antioxidants from food and supplement industries, contribute to the significant share of the Asia-Pacific region in the global astaxanthin market. Major markets in the Asia-Pacific region include China, India, and Australia-New Zealand.
Break-up of Primaries: By Company Type – Tier 1- 40 %, Tier 2- 40 %, Tier 3- 20 % By Designation – C level-20 %, Directors-40 %, Others- 40 % By Region – North America-25 %, Europe-50 %, and Asia-Pacific- 25 %
Leading players profiled in this report are as follows:
• Koninklijke DSM N. V.( Netherlands)
• BASF SE( Germany)
• Cyanotech Corporation( U. S.)
• Otsuka Pharmaceuticals Co., Ltd.( Japan)
• Valensa International( U. S.)
• Fuji Chemical Industries CO., Ltd.( Japan)
• Divis Laboratories Ltd.( India)
• Beijing Ginko Group( China)
• Igene Biotechnology, Inc.( U. S.)
• Piveg, Inc.( U. S.)
• Fenchem Biotek, Ltd.( U. S.)
• Algatechnologies( Israel)
• Cardax, Inc.( U. S.)
• Supreme Biotechnologies( New Zealand)
Study Coverage:
The astaxanthin market has been segmented on the basis of source, application, form, and method of production, which are further divided into their subsegments. It has also been segmented on the basis of region into North America, Europe, Asia-Pacific and the Rest of the World( RoW).
Reasons to buy this report:
• To get a comprehensive overview of the global astaxanthin market
• To gain wide-ranging information about the top players in this industry, their product portfolios, and key strategies adopted by the players.
• To gain insights of the countries / regions in the astaxanthin industry
TABLE OF CONTENTS